Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Mem. Inst. Oswaldo Cruz ; 115: e200113, 2020. tab, graf
Artigo em Inglês | LILACS, SES-SP | ID: biblio-1135235

RESUMO

BACKGROUND Lutzomyia longipalpis-derived cell line (Lulo) has been suggested as a model for studies of interaction between sandflies and Leishmania. OBJECTIVES Here, we present data of proteomic and gene expression analyses of Lulo cell related to interactions with Leishmania (Viannia) braziliensis. METHODS Lulo cell protein extracts were analysed through a combination of two-dimensional gel electrophoresis and mass spectrometry and resulting spots were further investigated in silico to identify proteins using Mascot search and, afterwards, resulting sequences were applied for analysis with VectorBase. RESULTS Sixty-four spots were identified showing similarities to other proteins registered in the databases and could be classified according to their biological function, such as ion-binding proteins (23%), proteases (14%), cytoskeletal proteins (11%) and interactive membrane proteins (9.5%). Effects of interaction with L. (V.) braziliensis with the expression of three genes (enolase, tubulin and vacuolar transport protein) were observed after an eight-hour timeframe and compared to culture without parasites, and demonstrated the impact of parasite interaction with the expression of the following genes: LLOJ000219 (1.69-fold), LLOJ000326 (1.43-fold) and LLOJ006663 (2.41-fold). CONCLUSIONS This set of results adds relevant information regarding the usefulness of the Lulo cell line for studies with Leishmania parasites that indicate variations of protein expression.


Assuntos
Animais , Psychodidae/parasitologia , Leishmania braziliensis/genética , Proteômica , Leishmania/genética , Linhagem Celular , Transcriptoma
2.
Mem. Inst. Oswaldo Cruz ; 115: e190401, 2020. tab
Artigo em Inglês | LILACS, SES-SP | ID: biblio-1135285

RESUMO

Bacillus Calmette Guerin (BCG) vaccines comprise a family of related strains. Whole genome sequencing has allowed the better characterisation of the differences between many of the BCG vaccines. As sequencing technologies improve, updating of publicly available sequence data becomes common practice. We hereby announce the draft genome of four commonly used BCG vaccines in Brazil, Argentina and Venezuela.


Assuntos
Humanos , Vacina BCG/genética , Mapeamento Cromossômico , Mycobacterium bovis/genética , Argentina , Venezuela , Brasil , Dados de Sequência Molecular , Sequência de Bases , Polimorfismo de Nucleotídeo Único
3.
Mem. Inst. Oswaldo Cruz ; 113(11): e180267, 2018. graf
Artigo em Inglês | LILACS | ID: biblio-1040585

RESUMO

The Bacille Calmette-Guérin (BCG) vaccine comprises a family of genetically different strains derived by the loss of genomic regions (RDs) and other mutations. In BCG Moreau, loss of RD16 inactivates rv3405c * , encoding a transcriptional repressor that negatively regulates the expression of Rv3406, an alkyl sulfatase. To evaluate the impact of this loss on the BCG and host cell viability and the cytokine profile, THP-1 cells were infected with BCG Moreau (harbouring the empty vector) and a complemented strain carrying a functional copy of rv3405c. Viability of the host cells and bacteria as well as the pattern of cytokine secretion were evaluated. Our results show that the viability of BCG Moreau is higher than that of the complemented strain in an axenic medium, suggesting a possible functional gain associated with the constitutive expression of Rv3406. Viability of the host cells did not vary significantly between recombinant strains, but differences in the profiles of the cytokine secretion (IL-1β and IL-6) were observed. Our results suggest an example of a functional gain due to gene loss contributing to the elucidation of the impact of RD16 on the physiology of BCG Moreau.


Assuntos
Humanos , Transcrição Gênica/genética , Vacina BCG/farmacologia , Sobrevivência Celular/genética , Citocinas/efeitos dos fármacos , Mutação com Ganho de Função/genética , Macrófagos/microbiologia , Mycobacterium bovis/genética , Fatores de Tempo , Transcrição Gênica/efeitos dos fármacos , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/microbiologia , Vacina BCG/genética , Sobrevivência Celular/efeitos dos fármacos , Citocinas/genética , Mutação com Ganho de Função/efeitos dos fármacos , Mycobacterium bovis/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA